Insider · CIK 0001324617

Skyline Venture Partners Qualified Purchaser Fund IV L P

Reports to the SEC for 6 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001324617

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-10-27	TARAProtara Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+200K sh	$10.00	+$2M	200,000
2014-10-27	TARAProtara Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.17M sh	—	—	1,367,208
2014-10-27	TARAProtara Therapeutics, Inc.X Exercise of In-Money	10% Owner	XExercise of In-Money	+122K sh	$4.60	+$560K	1,488,968
2014-10-27	TARAProtara Therapeutics, Inc.S Sale	10% Owner	SSale	−56K sh	$10.00	−$560K	1,432,930
2014-10-27	TARAProtara Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−5M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series A-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−2.34M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−2.17M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−2.44M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−3.93M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Warrants (Right to Buy)X Exercise of In-Money	10% Owner	XExercise of In-Money	−122K sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Option (Right to Purchase)J Other	10% Owner	JOther	−1.39M sh	—	—	0
2014-03-12	TETRAPHASE PHARMACEUTICALS INCJ Other	10% Owner	JOther	−300K sh	—	—	1,890,146
2014-03-12	TETRAPHASE PHARMACEUTICALS INCJ Other	10% Owner	JOther	+4,493 sh	—	—	4,493
2014-03-07	TLPHTALPHERA, INC.J Other	Former 10% Holder	JOther	−1.3M sh	—	—	2,871,933
2014-02-20	CONCERT PHARMACEUTICALS, INC.C Conversion	10% Owner	CConversion	+389K sh	—	—	421,752
2014-02-20	CONCERT PHARMACEUTICALS, INC.C Conversion	10% Owner	CConversion	+531K sh	—	—	952,726
2014-02-20	CONCERT PHARMACEUTICALS, INC.C Conversion	10% Owner	CConversion	+106K sh	—	—	1,058,920
2014-02-20	CONCERT PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+150K sh	$14.00	+$2.1M	1,208,920
2014-02-20	CONCERT PHARMACEUTICALS, INC.Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−2.2M sh	—	—	0
2014-02-20	CONCERT PHARMACEUTICALS, INC.Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−3M sh	—	—	0
2014-02-20	CONCERT PHARMACEUTICALS, INC.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−600K sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+72.1K sh	—	—	82,414
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+94K sh	—	—	176,417
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+394K sh	—	—	570,280
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+939K sh	—	—	1,509,133
2013-03-25	TETRAPHASE PHARMACEUTICALS INCP Purchase	10% Owner	PPurchase	+681K sh	$7.00	+$4.77M	2,190,145
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries A-1 Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−2.09M sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries A-2 Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−2.73M sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries B Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−11.4M sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries C Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−27.2M sh	—	—	0
2012-05-29	TLPHTALPHERA, INC.P Purchase	Former 10% Holder	PPurchase	+285K sh	$3.40	+$968K	4,161,933
2012-05-29	TLPHTALPHERA, INC. · Warrant to purchase Common StockP Purchase	Former 10% Holder	PPurchase	+256K sh	$0.13	+$32K	256,228
2011-02-16	TLPHTALPHERA, INC.C Conversion	Former 10% Holder	CConversion	+683K sh	—	—	682,904
2011-02-16	TLPHTALPHERA, INC.C Conversion	Former 10% Holder	CConversion	+469K sh	—	—	1,151,568
2011-02-16	TLPHTALPHERA, INC.C Conversion	Former 10% Holder	CConversion	+916K sh	—	—	2,067,366
2011-02-16	TLPHTALPHERA, INC.C Conversion	Former 10% Holder	CConversion	+555K sh	—	—	2,622,051
2011-02-16	TLPHTALPHERA, INC.C Conversion	Former 10% Holder	CConversion	+29.2K sh	—	—	2,651,292
2011-02-16	TLPHTALPHERA, INC.P Purchase	Former 10% Holder	PPurchase	+1.24M sh	$5.00	+$6.18M	3,877,235
2011-02-16	TLPHTALPHERA, INC. · Series A Convertible Preferred StockC Conversion	Former 10% Holder	CConversion	−500K sh	—	—	0
2011-02-16	TLPHTALPHERA, INC. · Series B Convertible Preferred StockC Conversion	Former 10% Holder	CConversion	−313K sh	—	—	0
2011-02-16	TLPHTALPHERA, INC. · Series C Convertible Preferred StockC Conversion	Former 10% Holder	CConversion	−916K sh	—	—	0
2011-02-16	TLPHTALPHERA, INC. · Convertible Promissory NoteC Conversion	Former 10% Holder	CConversion	—	—	—	0
2011-02-16	TLPHTALPHERA, INC. · Warrant to purchase Series C Convertible Preferred StockX Exercise of In-Money	Former 10% Holder	XExercise of In-Money	−125K sh	—	—	0
2011-02-16	TLPHTALPHERA, INC. · Series C Convertible Preferred StockX Exercise of In-Money	Former 10% Holder	XExercise of In-Money	+125K sh	—	—	125,386
2011-02-16	TLPHTALPHERA, INC. · Series C Convertible Preferred StockS Sale	Former 10% Holder	SSale	−98.9K sh	—	—	26,511
2011-02-16	TLPHTALPHERA, INC. · Series C Convertible Preferred StockC Conversion	Former 10% Holder	CConversion	−26.5K sh	—	—	0
2011-02-16	TLPHTALPHERA, INC. · Warrant to purchase Series C Convertible Preferred StockJ Other	Former 10% Holder	JOther	+12.9K sh	—	—	12,914
2011-02-16	TLPHTALPHERA, INC. · Warrant to purchase Series C Convertible Preferred StockX Exercise of In-Money	Former 10% Holder	XExercise of In-Money	−12.9K sh	—	—	0
2011-02-16	TLPHTALPHERA, INC. · Series C Convertible Preferred StockX Exercise of In-Money	Former 10% Holder	XExercise of In-Money	+12.9K sh	—	—	12,914
2011-02-16	TLPHTALPHERA, INC. · Series C Convertible Preferred StockS Sale	Former 10% Holder	SSale	−10.2K sh	—	—	2,730

Recent filings

Accepted (ET)
Oct 294
PROTEON THERAPEUTICS INC0001104659-14-074955
SEC(opens sec.gov)
Mar 144
TETRAPHASE PHARMACEUTICALS INC0001104659-14-019715
SEC(opens sec.gov)
Mar 114
ACELRX PHARMACEUTICALS INC0001104659-14-018559
SEC(opens sec.gov)
Feb 214
CONCERT PHARMACEUTICALS, INC.0001104659-14-012353
SEC(opens sec.gov)

Companies

Address

525 UNIVERSITY AVE.

PALO ALTO, CA, 94301